Rosemary has been part of Mediterranean culture for centuries, but tradition alone is not evidence of efficacy.
What makes it interesting from a dermatological perspective today is its complex phytochemistry and the growing body of research into its potential effects on the skin and hair follicle.
At the same time, the word “rosemary” conceals an important distinction.
Rosemary leaf extract, rosemary essential oil and a finished cosmetic formulation are not the same thing.
01 / ROSEMARY IS NOT A SINGLE ACTIVE MOLECULE
Rosemary essential oil is a complex mixture of volatile compounds, commonly including 1,8-cineole, α-pinene, camphor and borneol.
Their proportions are not constant. The chemical profile depends on the plant chemotype, geographical origin, growing conditions, harvesting and extraction method.
Rosemary leaf extracts may contain other, less volatile phenolic and diterpenoid compounds.
This distinction becomes important when we try to explain mechanisms of action.
Evidence obtained with a leaf extract cannot automatically be attributed to rosemary essential oil — and certainly not to every cosmetic product labelled rosemary.
02 / WHY IS ROSEMARY INTERESTING IN ANDROGENETIC ALOPECIA?
In genetically susceptible hair follicles, dihydrotestosterone, or DHT, participates in the process of progressive follicular miniaturisation.
Testosterone is converted into DHT by the enzyme 5α-reductase. DHT then binds to androgen receptors in dermal papilla cells. In susceptible follicles, androgen signalling contributes to a shorter anagen phase and the progressive production of thinner, shorter hairs.
This is where an interesting connection with rosemary emerges.
Experimental research on Rosmarinus officinalis leaf extract has demonstrated inhibition of 5α-reductase activity. 12-methoxycarnosic acid was identified as one of the active components, and effects associated with androgen receptor activity have also been investigated.
But this does not demonstrate that rosemary essential oil applied to the human scalp clinically “blocks DHT”.
It is a mechanistic signal that justifies further investigation.
03 / ROSEMARY IS NOT ONLY A DHT STORY
Experimental studies of rosemary essential oil have described anti-inflammatory, antioxidant and antimicrobial activity.
Mechanisms involving NF-κB signalling and arachidonic acid metabolism, among others, have been investigated.
Antimicrobial activity has also been demonstrated in laboratory settings, and the complete essential-oil mixture does not necessarily behave in the same way as its isolated individual components.
This illustrates an important principle in botanical research.
A plant extract or essential oil is not one molecule with one mechanism. It is a chemical mixture whose effects depend on its composition, concentration and the biological system in which it is studied.
Claims such as “rosemary works because it increases circulation” therefore oversimplify a much more complex story.
04 / WHAT HAS ACTUALLY BEEN SHOWN IN HUMANS?
The best-known clinical study involved 100 people with androgenetic alopecia.
One group used a rosemary preparation and the other 2% minoxidil for six months.
After three months, neither group showed a significant increase in hair count. After six months, hair count had increased significantly from baseline in both groups, with no statistically significant difference between the groups at that time point.
That is an interesting finding.
But it has often been turned into a claim the study did not establish:
“Rosemary is as effective as minoxidil.”
Failure to detect a statistically significant difference is not the same as demonstrating equivalence.
That would require a study specifically designed as an equivalence or non-inferiority trial, with appropriate statistical power.
A more accurate conclusion is that there is a limited but clinically interesting signal of activity that deserves further investigation.
05 / FORMULATION DETERMINES WHETHER BIOLOGY BECOMES RELEVANT
A biologically active molecule in a laboratory is not yet an effective topical product.
After application, it must remain sufficiently stable, be released from the formulation, come into contact with the skin, reach a biologically relevant site at an adequate concentration and remain sufficiently well tolerated.
The presence of rosemary on an INCI list therefore tells us very little on its own about the biological relevance of a product.
Concentration, chemical profile, vehicle, stability and interaction with the rest of the formulation all matter.
This is why rosemary is not considered an isolated “hero ingredient” within EASTOK.
Its value exists within the formulation and within the protocol.
06 / NATURAL DOES NOT MEAN UNRESTRICTED
Rosemary essential oil is a concentrated mixture of bioactive compounds.
Natural origin does not mean that every concentration is appropriate for every scalp.
Essential oils can cause irritation and allergic contact dermatitis, particularly when used undiluted or on an already compromised skin barrier.
More is therefore not necessarily better.
The aim of good formulation is not to achieve the highest possible concentration of an active ingredient, but a concentration that makes sense within a particular vehicle while maintaining acceptable tolerability.
07 / SO WHERE DOES ROSEMARY BELONG?
Rosemary occupies an interesting space between tradition and pharmacology.
We have experimental evidence concerning antiandrogenic mechanisms of leaf extracts, research into the anti-inflammatory and antimicrobial properties of the essential oil, and limited clinical data in androgenetic alopecia.
What we do not have is sufficient evidence to call rosemary a treatment for hair loss.
That does not diminish its value.
It allows us to use it without asking it to carry claims the evidence cannot support.
BETWEEN TRADITION AND EVIDENCE
Rosemary belongs naturally to the Mediterranean landscape from which EASTOK emerged.
But tradition explains why the plant is familiar to us.
Science must help explain why we choose to place it in a formulation.
We do not need to call rosemary “natural minoxidil” to justify its place in scalp care.
Its phytochemistry, biological activity and early clinical evidence are interesting enough — provided that we clearly distinguish what we know from what remains to be investigated.